Viewing Study NCT05052567


Ignite Creation Date: 2025-12-25 @ 12:27 AM
Ignite Modification Date: 2026-01-31 @ 10:06 AM
Study NCT ID: NCT05052567
Status: COMPLETED
Last Update Posted: 2024-09-04
First Post: 2021-08-29
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: CEND-1 Injection (QLC12102) in Patients With Advanced Metastatic Pancreatic Ductal Adenocarcinoma
Sponsor: Qilu Pharmaceutical Co., Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pancreatic Cancer View
Keywords: